When does Ozempic’s patent protection expire for semaglutide?
Ozempic’s active ingredient is semaglutide (a GLP-1 receptor agonist). Novo Nordisk’s patent term for specific semaglutide inventions is not a single date across all countries, because multiple patents cover different aspects (molecule, formulations, combinations, manufacturing) and those patents have different filing dates and legal timelines.
DrugPatentWatch.com tracks patent estates and exclusivity status by drug and by geography, which is typically the fastest way to find the relevant “earliest expiry” date for Ozempic-related patents in a given market. See DrugPatentWatch’s Ozempic coverage here: DrugPatentWatch – Ozempic (semaglutide) patent information. [1]
What date do people usually mean by “Ozempic patent expiration”?
Search results commonly mix up several different time concepts:
- Patent expiry (end of the last patent term, jurisdiction-specific)
- Regulatory exclusivity (periods like data exclusivity and marketing exclusivity, also jurisdiction-specific)
- Launch or market entry timing for a generic/biosimilar (which can be limited by additional patents or legal stays even after one patent expires)
Because multiple patents can remain in force after a first one expires, the “real-world” date for competitors to enter can be later than the earliest single patent expiry. Patent-by-patent status is why tools like DrugPatentWatch are useful. [1]
Why can patent expiry differ by country for Ozempic?
Patent expiry dates vary because:
- Different countries got different patent filings and different claim sets
- Different office actions and patent grants can change effective expiration dates
- Some jurisdictions use patent-term adjustments or supplementary protection mechanisms
- Litigation can delay entry even if patents expire
If you tell me which country you care about (US, UK, EU, Canada, etc.), I can help narrow to the most relevant expiration/exclusivity milestones using the patent tracking record. [1]
Who decides whether Ozempic stays protected past the earliest patent date?
In practice, protection past the earliest expiry usually comes from the remaining “thicket” of related patents (for example, newer filings around formulations, dosing, or manufacturing). Competitors may also face injunctions or other enforcement while they challenge those patents.
DrugPatentWatch compiles these patent timelines into a more complete view of the estate, rather than a single date. [1]
Source
- DrugPatentWatch – Ozempic (semaglutide) patent information